WASHINGTON (AP) -- The Food and Drug Administration is warning women of child-bearing age that the epilepsy drug Topamax can increase the risk of birth defects around the mouth.
Data collected from a registry of pregnant women showed a higher rate of cleft lip and cleft palate in babies whose mothers were taking the drug during the first trimester.
Topamax is marketed by Johnson & Johnson to control seizures caused by epilepsy, a neurological disorder that causes excessive signals in the brain. The drug is also used to relieve migraine headaches.
J&J and generic drugmakers who market the drug, known as topiramate, will add a stronger warning label about the drug's effect on pregnancies.
Women taking topiramate should talk to their doctor immediately if they are planning to or become pregnant.
Viewers with disabilities can get assistance accessing this station's FCC Public Inspection File by contacting the station with the information listed below. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, 888-835-5322 (TTY), or firstname.lastname@example.org.